Poseida Therapeutics, Inc.
SEC CIK 1661460 · PSTX · last insider filing 2025-01-10
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Gergen Mark J | Director · President and CEO | filed 2020 - 2025 |
| Lloyd Marcea Bland | Director | filed 2020 - 2025 |
| Collins Cynthia | Director | filed 2021 - 2025 |
| Schmid John P. | Director | filed 2020 - 2025 |
| Baum Charles M | Director | filed 2022 - 2025 |
| Amado Rafael | Director | filed 2023 - 2025 |
| Yarema Kristin | Director · President, Cell Therapy | filed 2023 - 2025 |
| Corning Luke | Director | filed 2020 - 2025 |
| Ostertag Eric | Director · Executive Chairman | filed 2020 - 2023 |
| Hirsch David | Director | filed 2020 - 2021 |
| Murphy Sean | Director | filed 2020 - 2020 |
| Mackey Catherine J | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Leonhardt Harry J | GC & Chief Compliance Officer | filed 2020 - 2025 |
| Mylet Johanna | Senior Vice President, Finance | filed 2020 - 2025 |
| Rizvi Syed Ali-Aamir | Chief Medical Officer | filed 2024 - 2025 |
| Warner Brent | President, Gene Therapy | filed 2022 - 2024 |
| Ingalls Kerry D. | Chief Operating Officer | filed 2020 - 2022 |
| Spear Matthew A. | Chief Medical Officer | filed 2020 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.